Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprolide Acetate for Pedophilia
NCT00220350Phase 3Unknown
- Start
- Oct 2001
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind, single-arm trial of leuprolide in pedophilic disorder. Primary endpoint: Suppressed Physiological Arousal at 24 months. Status: unknown.
02
Drugs
leuprolide
03
Conditions
pedophilic disorder
Beyond the preview
Go deeper on NCT00220350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00220350.